Palatin Technologies, Inc.
PTN
Rank in Stocks
#27956
Palatin Technologies, Inc., a biopharmaceutical company, develops... Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, as well as Bremelanotide co-formulated with a PDE5i for the treatment of ED in patients not adequately responsive to PDE5i monotherapy. The company also develops PL9643 for dry eye disease and anti-inflammatory ocular indications; and oral PL8177 for the treatment inflammatory bowel diseases. Palatin Technologies, Inc. was incorporated in 1986 and is based in Monmouth Junction, New Jersey.
Share Price
$7.23
Last synced: 2026-11-09
Market Cap
$12.88M
Change (1 day)
15.31%
Change (1 year)
-15.24%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Palatin Technologies, Inc. (PTN)
Category
Healthcare
EPS for Palatin Technologies, Inc. (PTN)
EPS as of June 2026 TTM: $-5.25
According to Palatin Technologies, Inc.'s latest financial reports, its current EPS (TTM) is $-5.25. At the end of 2025 the company had an EPS of $-32.15, a decrease compared to its 2024 EPS of $-2.02.
EPS history for Palatin Technologies, Inc. from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-5.25 | -83.67% |
| 2025 | $-32.15 | 1,491.58% |
| 2024 | $-2.02 | -8.60% |
| 2023 | $-2.21 | -41.69% |
| 2022 | $-3.79 | 6.76% |
| 2021 | $-3.55 | 49.16% |
| 2020 | $-2.38 | -155.22% |
| 2019 | $4.31 | 38.14% |
| 2018 | $3.12 | -272.38% |
| 2017 | $-1.81 | -78.09% |
| 2016 | $-8.26 | 126.30% |
| 2015 | $-3.65 | 11.96% |
| 2014 | $-3.26 | -38.95% |
| 2013 | $-5.34 | -56.80% |
| 2012 | $-12.36 | -22.51% |
| 2011 | $-15.95 | 251.32% |
| 2010 | $-4.54 | -67.34% |
| 2009 | $-13.90 | -67.06% |
| 2008 | $-42.20 | -53.65% |
| 2007 | $-91.04 | -24.10% |
| 2006 | $-119.95 | 80.00% |
| 2005 | $-66.64 | -51.70% |
| 2004 | $-137.97 | -23.89% |
| 2003 | $-181.27 | -36.22% |
| 2002 | $-284.23 | 8.67% |
| 2001 | $-261.55 | -4.87% |
| 2000 | $-274.94 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -398.29% |
US
|
|
| $-7.07 | 34.67% |
US
|
|
| $-5.29 | 0.76% |
AU
|
|
| $12.88 | -345.34% |
BE
|
|
| $21.56 | -510.67% |
NL
|
Questions about Palatin Technologies, Inc.'s earnings per share (EPS)
What is Palatin Technologies, Inc.'s earnings per share (EPS)?
Palatin Technologies, Inc.'s earnings per share (EPS) over the last twelve months is $-5.25, as of Jun 2026.
What was Palatin Technologies, Inc.'s earnings per share (EPS) in 2025?
In 2025, Palatin Technologies, Inc.'s earnings per share (EPS) was $-32.15, compared with $-2.02 in 2024.
How has Palatin Technologies, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Palatin Technologies, Inc.'s earnings per share (EPS) was highest in 2024 ($-2.02) and lowest in 2025 ($-32.15).
How does Palatin Technologies, Inc.'s earnings per share (EPS) compare with similar companies?
Palatin Technologies, Inc.'s earnings per share (EPS) ($-5.25) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.